Prime Minister Justin Trudeau signed an agreement with Novavax to produce their COVID-19 vaccine in Montreal after approvals for widespread distribution. BNN Bloomberg's David George-Cosh has the details.
Everyday Living® Your information source for products, shopping, marketing and business services, health matters, home and garden, food and lesiure, weight loss, anti-ageing surgical procedures and non-surgical rejuvenation treatments. www.everydayliving.com®
Wednesday, October 20, 2021
Canada announced agreement with Novavax to produce vaccine in Montreal
Canada announced agreement with Novavax to produce vaccine in Montreal:
Tuesday, October 19, 2021
Novavax applies to WHO for emergency listing of COVID-19 vaccine
Novavax applies to WHO for emergency listing of COVID-19 vaccine:
Novavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing of Novavax's COVID-19 vaccine.
Saturday, October 16, 2021
Tuesday, October 12, 2021
Health Canada suspends licence, issues recall for hand sanitizer containing 'elevated levels' of methanol
Health Canada suspends licence, issues recall for hand sanitizer containing 'elevated levels' of methanol: Health Canada has issued a recall and suspended the licence for PURE75 gel hand sanitizer after learning the product contains 'elevated levels' of methanol that can cause serious health issues such as skin and eye irritation, breathing problems, headaches and even death.
Saturday, October 9, 2021
Friday, October 8, 2021
Merck’s New COVID Drug
Merck’s New COVID Drug Is Making News — How Does It Compare to Ivermectin?
In his latest video, John Campbell, Ph.D., compared ivermectin, whose use as a COVID treatment has been widely criticized by mainstream media, with Merck’s new COVID drug, Molnupiravir, which is garnering positive media coverage.
Subscribe to: Posts (Atom)